Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme

被引：0
|
作者：
Spencer, Harold T. [1 ]
Pereboeva, Larisa [2 ]
Gillespie, George Y. [3 ]
Dasgupta, Anindya [1 ]
Sutton, Kathryn S. [1 ]
Lamb, Lawrence S. [2 ]
机构：
[1] Emory Univ, Pediat, Atlanta, GA 30322 USA
[2] Univ Alabama Birmingham, Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Neurosurg, Birmingham, AL USA
来源：
MOLECULAR THERAPY | 2015年 / 23卷
关键词：
D O I：
10.1016/S1525-0016(16)33896-5
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
287
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [1] Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
    Spencer, Harold Trent
    Dasgupta, Anindya
    Gillespie, George Yancey
    Pereboeva, Larisa
    Sutton, Kathryn S.
    Lamb, Lawrence
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S240 - S240
  • [2] Improved outcomes with drug-resistant immunotherapy in a human xenograft model of glioblastoma multiforme
    Langford, Samantha B.
    Spencer, Harold T.
    Dasgupta, Anindya
    Gillespie, George Y.
    Sutton, Kathryn
    Pereboeva, Larisa
    Lamb, Lawrence S.
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Multidimensional hydrogel model to benchmark progression of temozolomide-resistant glioblastoma
    Kriuchkovskaia, Viktoriia
    Harley, Brendan A.
    Riggins, Rebecca B.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [4] Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme
    Teraiya, Milan
    Krokhin, Oleg
    Chen, Vincent C.
    Perreault, Helene
    [J]. JOURNAL OF PROTEOME RESEARCH, 2023, 23 (01) : 465 - 482
  • [5] Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
    Gong, Lingli
    Yin, Ying
    Chen, Cheng
    Wan, Quan
    Xia, Die
    Wang, Mei
    Pu, Zhening
    Zhang, Bo
    Zou, Jian
    [J]. CELL DEATH DISCOVERY, 2022, 8 (01)
  • [6] Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
    Lingli Gong
    Ying Yin
    Cheng Chen
    Quan Wan
    Die Xia
    Mei Wang
    Zhening Pu
    Bo Zhang
    Jian Zou
    [J]. Cell Death Discovery, 8
  • [7] TEMOZOLOMIDE-RESISTANT CAR-T ENHANCES GLIOBLASTOMA CLEARANCE BY CONCURRENT CHEMOTHERAPY AND IMMUNOTHERAPY
    Sampath, Prakash
    Sengupta, Sadhak
    Sengupta, Sudarshana
    Junghans, Richard
    [J]. NEURO-ONCOLOGY, 2017, 19 : 112 - 112
  • [8] Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma
    Guo, Gao
    Gong, Ke
    Puliyappadamba, Vineshkumar Thidil
    Panchani, Nishah
    Pan, Edward
    Mukherjee, Bipasha
    Damanwalla, Ziba
    Bharia, Sabrina
    Hatanpaa, Kimmo J.
    Gerber, David E.
    Mickey, Bruce E.
    Patel, Toral R.
    Sarkaria, Jann N.
    Zhao, Dawen
    Burma, Sandeep
    Habib, Amyn A.
    [J]. NEURO-ONCOLOGY, 2019, 21 (12) : 1529 - 1539
  • [9] Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells
    Zampieri, Luca X.
    Sboarina, Martina
    Cacace, Andrea
    Grasso, Debora
    Thabault, Leopold
    Hamelin, Loic
    Vazeille, Thibaut
    Dumon, Elodie
    Rossignol, Rodrigue
    Frederick, Raphael
    Sonveaux, Etienne
    Lefranc, Florence
    Sonveaux, Pierre
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [10] Concurrent chemotherapy and temozolomide-resistant CAR-T immunotherapy enhances glioblastoma clearance in experimental animals
    Sengupta, Sadhak
    Gergi, Mansour
    Guha, Prajna
    Sengupta, Sudarshana
    Junghans, Richard P.
    Sampath, Prakash
    [J]. CANCER RESEARCH, 2018, 78 (13)
12345